Importantly, we found that patients with low systolic blood pressure, in particular those without hypertension, and high NT-proBNP levels indicative of heart failure, benefit from P-IABP, as early pre-interventional implantation reduces the risk of high peri-interventional myocardial injury seen with R-IABP. The gene discussed is NPPB; the disease is Hypertension.